Digitisation | September 13, 2023
AI to transform all processes in drug development by 2026, predicts CPHI Report
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
CMOs showed an increasing reluctance to take on debt in 2022
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Subscribe To Our Newsletter & Stay Updated
